A Pilot Study of Early Postpartum Intrauterine Contraception

Inclusion Criteria: * Currently pregnant with a single gestation of at least 27 completed weeks estimated gestational age, with no complications of pregnancy including, but not limited to, preeclampsia, non-gestational diabetes, anemia. * Desires to use intrauterine contraception (IUD) after delivery * Anticipates having a vaginal delivery * No intention to leave the area 7 months after enrollment * Able to consent to participate in the study in English * Has no known uterine anomalies * Has no allergies to any components of the intrauterine contraception Exclusion Criteria: * Prior cesarean delivery * Having been treated for pelvic inflammatory disease within 3 months prior to the start of the pregnancy * Allergic to betadine * Allergy to lidocaine * Medical or personal conditions which in the judgment of study staff contradict participation in the study * Any contraindications to use of the levonorgestrel-releasing intrauterine contraceptive system which includes: known or suspected breast carcinoma, acute liver disease or liver tumor, history of ectopic pregnancy, cervical cancer or carcinoma in situ * After enrollment, and after delivery of the infant but before IUD insertion subjects will be excluded by checking with the attending obstetric physician and/or obstetric medical chart for the following: * Endometritis or chorioamnionitis during the intrapartum period * Membranes ruptured for greater than 24 hours prior to delivery * Fever greater than or equal to 3…